Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | D. Kobelt et al., Mol. Oncology, 2014, 8: 209-619, doi.org/10.1016/j.molonc.2013.12.019 | Link | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | D. Kobelt, Dissertation, 2012, Humboldt-Universität zu Berlin | Link | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | |||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Konina et al., Int. J. Mol. Sci., 2021, 22, 8477, doi.org/10.3390/ijms22168477 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. O. Konina et al., BMC Genomics, 2019, 20 Suppl 3: 298, doi.org/10.1186/s12864-019-5538-z | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Clinical and Translational Medicine, 2014, 3:1, doi:10.1186/2001-1326-3-1 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | A. Y. Filatova et al., Eur. J. of Human Genetics, 2019, 27: 488–493, doi.org/10.1038/s41431-018-0288-y | Link | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | E. Cesaro et al., Research Square, 2021, DOI: https://doi.org/10.21203/rs.3.rs-278700/v1 | Link | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | MIDGE | Metafectene | publication | D. Kobelt, Dissertation, 2012, Humboldt-Universität zu Berlin | Link | ||
A375-P |
Human melanona cell line | ATCC CRL-3224 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Raturi et al., J. Cell Biol., Aug 2016; 214, 433 - 444 | ||
A375-P |
Human melanona cell line | ATCC CRL-3224 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | A. Raturi et al., J. Cell Biol., Aug 2016; 214, 433 - 444 | |||
A375-P |
Human melanona cell line | ATCC CRL-3224 | Human | skin | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | A. Raturi et al., J. Cell Biol., Aug 2016; 214, 433 - 444 | ||
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Rungaldier et al., PLOSONE, June 2017, https://doi.org/10.1371/journal.pone.0178646 | Link | |
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | S. Rungaldier et al., PLOSONE, June 2017, https://doi.org/10.1371/journal.pone.0178646 | Link | ||
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | E. Umlauf et al., J. Biol. Chem., May 2004; 279: 23699 - 23709 | Link | ||
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | H. Kobayashi et al., J. Biol. Chem., Nov 2011; 286: 39259 - 39268 | Link | ||
B-16 |
Mouse skin melanoma cell line | Mouse | skin | cell line | adherent | plasmid | Metafectene | publication | S.-B. Varda et al., 2012, EP 2 371 846 | Link | |||
B16 |
Mouse melanoma cell line | Mouse | skin | cell line | adherent | plasmid | Metafectene | publication | V. Shoshan-Barmatz et al., 2014, US 8,648,045 (Patent) | Link | |||
B16F0 |
Mouse melanoma cell line | ATCC CRL 6475 | Mouse | skin | cell line | adherent | plasmid | Metafectene PRO | publication | C.D. Krause et al., Stem Cell Res Ther, Jan 2011; 2(2): 15 | |||
B16F0 |
Mouse melanoma cell line | ATCC CRL 6475 | Mouse | skin | cell line | adherent | plasmid | Metafectene EASY | publication | C. D. Krause et al., Cell Res. & Therapy, 2011, 2:15, doi:10.1186/scrt56 | Link |